Candidiasis Therapeutics Market Report

Global and Region Candidiasis Therapeutics Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：211
  • REPORT CODE：GMM926715
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Candidiasis Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Candidiasis Therapeuticsmarket, defines the market attractiveness level of Candidiasis Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Candidiasis Therapeutics industry, describes the types of Candidiasis Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Candidiasis Therapeutics market and the development prospects and opportunities of Candidiasis Therapeutics industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Candidiasis Therapeutics market in Chapter 13.

    By Player:

    • Catena Pharmaceuticals Inc

    • Medivir AB

    • Genta Incorporated

    • F Hoffmann-La Roche Ltd

    • Digna Biotech SL

    • Amura Holdings

    • Amgen

    • Ablynx

    • Merrion Pharmaceuticals Plc

    • Galapagos NV

    • Novartis AG

    • Bayer-Algeta

    By Type:

    • Doxorubicin

    • Cisplatin

    • 7Carboplatin

    • Etoposide

    • Ifosfamide

    • Cyclophosphamide

    • Methotrexate

    • Vincristine

    By End-User:

    • Multispecialty Hospitals

    • Cancer Research Institutes

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Candidiasis Therapeutics Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Candidiasis Therapeutics Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Candidiasis Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Candidiasis Therapeutics Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Candidiasis Therapeutics Market Analysis and Outlook to 2022

    • 7.1 Global Candidiasis Therapeutics Consumption (2017-2022)

    • 7.2 United States Candidiasis Therapeutics Consumption (2017-2022)

    • 7.3 Europe Candidiasis Therapeutics Consumption (2017-2022)

    • 7.4 China Candidiasis Therapeutics Consumption (2017-2022)

    • 7.5 Japan Candidiasis Therapeutics Consumption (2017-2022)

    • 7.6 India Candidiasis Therapeutics Consumption (2017-2022)

    • 7.7 South Korea Candidiasis Therapeutics Consumption (2017-2022)

    8 Region and Country-wise Candidiasis Therapeutics Market Analysis and Outlook to 2028

    • 8.1 Global Candidiasis Therapeutics Consumption Forecast (2022-2028)

    • 8.2 United States Candidiasis Therapeutics Consumption Forecast (2022-2028)

    • 8.3 Europe Candidiasis Therapeutics Consumption Forecast (2022-2028)

    • 8.4 China Candidiasis Therapeutics Consumption Forecast (2022-2028)

    • 8.5 Japan Candidiasis Therapeutics Consumption Forecast (2022-2028)

    • 8.6 India Candidiasis Therapeutics Consumption Forecast (2022-2028)

    • 8.7 South Korea Candidiasis Therapeutics Consumption Forecast (2022-2028)

    9 Global Candidiasis Therapeutics Market Outlook by Types and Applications to 2022

    • 9.1 Global Candidiasis Therapeutics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Doxorubicin Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Cisplatin Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global 7Carboplatin Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Etoposide Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Ifosfamide Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Cyclophosphamide Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Methotrexate Consumption and Growth Rate (2017-2022)

      • 9.1.8 Global Vincristine Consumption and Growth Rate (2017-2022)

    • 9.2 Global Candidiasis Therapeutics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Multispecialty Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Cancer Research Institutes Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Candidiasis Therapeutics Market Outlook by Types and Applications to 2028

    • 10.1 Global Candidiasis Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Doxorubicin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Cisplatin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global 7Carboplatin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Etoposide Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Ifosfamide Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Cyclophosphamide Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.7 Global Methotrexate Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.8 Global Vincristine Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Candidiasis Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Multispecialty Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Cancer Research Institutes Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Candidiasis Therapeutics Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Candidiasis Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Candidiasis Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Candidiasis Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Candidiasis Therapeutics Market Competitive Analysis

    • 14.1 Catena Pharmaceuticals Inc

      • 14.1.1 Catena Pharmaceuticals Inc Company Details

      • 14.1.2 Catena Pharmaceuticals Inc Candidiasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Catena Pharmaceuticals Inc Candidiasis Therapeutics Product and Service

    • 14.2 Medivir AB

      • 14.2.1 Medivir AB Company Details

      • 14.2.2 Medivir AB Candidiasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Medivir AB Candidiasis Therapeutics Product and Service

    • 14.3 Genta Incorporated

      • 14.3.1 Genta Incorporated Company Details

      • 14.3.2 Genta Incorporated Candidiasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Genta Incorporated Candidiasis Therapeutics Product and Service

    • 14.4 F Hoffmann-La Roche Ltd

      • 14.4.1 F Hoffmann-La Roche Ltd Company Details

      • 14.4.2 F Hoffmann-La Roche Ltd Candidiasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 F Hoffmann-La Roche Ltd Candidiasis Therapeutics Product and Service

    • 14.5 Digna Biotech SL

      • 14.5.1 Digna Biotech SL Company Details

      • 14.5.2 Digna Biotech SL Candidiasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Digna Biotech SL Candidiasis Therapeutics Product and Service

    • 14.6 Amura Holdings

      • 14.6.1 Amura Holdings Company Details

      • 14.6.2 Amura Holdings Candidiasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Amura Holdings Candidiasis Therapeutics Product and Service

    • 14.7 Amgen

      • 14.7.1 Amgen Company Details

      • 14.7.2 Amgen Candidiasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Amgen Candidiasis Therapeutics Product and Service

    • 14.8 Ablynx

      • 14.8.1 Ablynx Company Details

      • 14.8.2 Ablynx Candidiasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Ablynx Candidiasis Therapeutics Product and Service

    • 14.9 Merrion Pharmaceuticals Plc

      • 14.9.1 Merrion Pharmaceuticals Plc Company Details

      • 14.9.2 Merrion Pharmaceuticals Plc Candidiasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Merrion Pharmaceuticals Plc Candidiasis Therapeutics Product and Service

    • 14.10 Galapagos NV

      • 14.10.1 Galapagos NV Company Details

      • 14.10.2 Galapagos NV Candidiasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Galapagos NV Candidiasis Therapeutics Product and Service

    • 14.11 Novartis AG

      • 14.11.1 Novartis AG Company Details

      • 14.11.2 Novartis AG Candidiasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Novartis AG Candidiasis Therapeutics Product and Service

    • 14.12 Bayer-Algeta

      • 14.12.1 Bayer-Algeta Company Details

      • 14.12.2 Bayer-Algeta Candidiasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Bayer-Algeta Candidiasis Therapeutics Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Candidiasis Therapeutics

    • Figure Candidiasis Therapeutics Picture

    • Table Global Candidiasis Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Candidiasis Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Candidiasis Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Candidiasis Therapeutics Consumption by Country (2017-2022)

    • Figure United States Candidiasis Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Europe Candidiasis Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure China Candidiasis Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Japan Candidiasis Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure India Candidiasis Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Candidiasis Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Global Candidiasis Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure United States Candidiasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Candidiasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Candidiasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Candidiasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Candidiasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Candidiasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Doxorubicin Consumption and Growth Rate (2017-2022)

    • Figure Global Cisplatin Consumption and Growth Rate (2017-2022)

    • Figure Global 7Carboplatin Consumption and Growth Rate (2017-2022)

    • Figure Global Etoposide Consumption and Growth Rate (2017-2022)

    • Figure Global Ifosfamide Consumption and Growth Rate (2017-2022)

    • Figure Global Cyclophosphamide Consumption and Growth Rate (2017-2022)

    • Figure Global Methotrexate Consumption and Growth Rate (2017-2022)

    • Figure Global Vincristine Consumption and Growth Rate (2017-2022)

    • Figure Global Multispecialty Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Cancer Research Institutes Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Doxorubicin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cisplatin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global 7Carboplatin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Etoposide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ifosfamide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cyclophosphamide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Methotrexate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Vincristine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Multispecialty Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cancer Research Institutes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Candidiasis Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Candidiasis Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    • Table Catena Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)

    • Table Catena Pharmaceuticals Inc Candidiasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Catena Pharmaceuticals Inc Candidiasis Therapeutics Product and Service

    • Table Medivir AB (Foundation Year, Company Profile and etc.)

    • Table Medivir AB Candidiasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Medivir AB Candidiasis Therapeutics Product and Service

    • Table Genta Incorporated (Foundation Year, Company Profile and etc.)

    • Table Genta Incorporated Candidiasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genta Incorporated Candidiasis Therapeutics Product and Service

    • Table F Hoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)

    • Table F Hoffmann-La Roche Ltd Candidiasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann-La Roche Ltd Candidiasis Therapeutics Product and Service

    • Table Digna Biotech SL (Foundation Year, Company Profile and etc.)

    • Table Digna Biotech SL Candidiasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Digna Biotech SL Candidiasis Therapeutics Product and Service

    • Table Amura Holdings (Foundation Year, Company Profile and etc.)

    • Table Amura Holdings Candidiasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amura Holdings Candidiasis Therapeutics Product and Service

    • Table Amgen (Foundation Year, Company Profile and etc.)

    • Table Amgen Candidiasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Candidiasis Therapeutics Product and Service

    • Table Ablynx (Foundation Year, Company Profile and etc.)

    • Table Ablynx Candidiasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ablynx Candidiasis Therapeutics Product and Service

    • Table Merrion Pharmaceuticals Plc (Foundation Year, Company Profile and etc.)

    • Table Merrion Pharmaceuticals Plc Candidiasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merrion Pharmaceuticals Plc Candidiasis Therapeutics Product and Service

    • Table Galapagos NV (Foundation Year, Company Profile and etc.)

    • Table Galapagos NV Candidiasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Galapagos NV Candidiasis Therapeutics Product and Service

    • Table Novartis AG (Foundation Year, Company Profile and etc.)

    • Table Novartis AG Candidiasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG Candidiasis Therapeutics Product and Service

    • Table Bayer-Algeta (Foundation Year, Company Profile and etc.)

    • Table Bayer-Algeta Candidiasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer-Algeta Candidiasis Therapeutics Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US